PEMAZYRE bemigatinin (tablets)

PEMAZYRE® (pemigatinib)

PEMAZYRE monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a
fibroblast growth factor receptor 2 (FGFR2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy1

Show me how this
self⁠–⁠directed learning material works